Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron. Liu J, Chandrashekar A, Sellers D, Barrett J, et al. Nature 2022 Jan 31. pii: 10.1038/s41586-022-04465.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Liu J, Chandrashekar A, Sellers D, Barrett J, et al. Vaccines Elicit Highly Conserved Cellular Immunity to SARS-CoV-2 Omicron. Nature 2022 Jan 31. pii: 10.1038/s41586-022-04465.
PMID: 35102312